Common Cold (Rhinovirus)

For the why behind the fact

Use this page to connect what you are memorizing.

Start with the overview when a class slide, Anki card, or qbank explanation feels too thin. Then use presentation and workup to recognize the condition, and differentials to separate look-alikes.

Overview


Plain-Language Overview

The common cold is a very frequent illness caused by viruses, primarily affecting the nose and throat. It leads to symptoms like a runny nose, sneezing, sore throat, and sometimes a mild cough. This condition mainly impacts the upper respiratory system, which includes the nose, sinuses, and throat. Although it can cause discomfort and disrupt daily activities, it usually resolves on its own without serious complications. The immune system responds to the viral infection, which causes the typical symptoms. It is highly contagious and spreads easily through droplets when an infected person coughs or sneezes.

Clinical Definition

Rhinoviruses are the most frequent cause of the common cold. They are small, nonenveloped, icosahedral, positive-sense single-stranded RNA viruses in the Picornaviridae family. Infection of respiratory epithelium and the host inflammatory response cause congestion, rhinorrhea, sore throat and cough. Illness is often mild but can trigger asthma or COPD exacerbations and sometimes lower-respiratory disease. Symptoms alone do not confirm rhinovirus as the cause.

Inciting Event

  • Exposure to virus-containing respiratory particles, close contact or contaminated hands can introduce rhinovirus to susceptible mucosa.

  • Direct contact with contaminated surfaces followed by hand-to-nose contact initiates infection.

  • Seasonal outbreaks often follow increased indoor crowding and cooler weather.

Latency Period

  • Incubation period ranges from 1 to 3 days after exposure to rhinovirus before symptom onset.

  • Symptoms commonly peak in the first few days; viral load, shedding duration and symptom severity do not follow one fixed timetable.

Diagnostic Delay

  • Symptoms overlap with other viral respiratory infections, leading to clinical misattribution.

  • Lack of specific diagnostic tests in routine practice results in empirical diagnosis.

  • Mild and self-limited nature often causes patients to delay seeking medical evaluation.

Clinical Presentation


Signs & Symptoms

  • Nasal congestion and rhinorrhea are common; mucus may become thicker or colored without a bacterial complication.

  • Sneezing and sore throat commonly occur early in illness.

  • Cough may reflect upper-airway irritation, secretions or airway inflammation; it should not automatically be attributed only to postnasal drip.

  • Mild fever or low-grade temperature is possible but high fever is uncommon.

  • Headache and malaise may accompany the viral infection.

History of Present Illness

  • Sore throat, congestion, sneezing and rhinorrhea often emerge over the first few days; their order and timing vary.

  • Most symptoms improve over about a week, but cough or congestion may last longer; persistent or worsening symptoms warrant reassessment.

  • Symptoms often peak around days 2-3. Mild fever can occur; severe systemic illness, breathing difficulty or dehydration requires evaluation for complications or another cause.

  • Mild headache and malaise may accompany upper respiratory symptoms.

Past Medical History

  • History of frequent upper respiratory infections increases likelihood of recurrent colds.

  • Chronic allergic rhinitis or asthma may exacerbate symptom severity.

  • Immunodeficiency states predispose to prolonged or complicated infections.

Family History

  • Most recurrent colds reflect exposure and limited type-specific immunity rather than a clear inherited syndrome; unusually severe or recurrent infections may warrant assessment for immune dysfunction.

  • Family members often share environmental exposures that increase transmission risk.

Physical Exam Findings

  • Nasal mucosa erythema and swelling with clear rhinorrhea are typical findings.

  • Pharyngeal erythema without exudate is commonly observed.

  • Mild cervical lymphadenopathy may be present due to immune activation.

  • Conjunctival injection can occasionally accompany symptoms.

  • Lungs are often clear in an uncomplicated cold, but normal auscultation alone does not exclude pneumonia or other lower-respiratory disease.

Diagnostic Workup


Diagnostic Criteria

A common-cold syndrome is usually diagnosed clinically. Symptoms overlap with influenza, COVID-19 and other infections, so clinical findings cannot establish rhinovirus specifically. NAAT may identify rhinovirus when testing affects care; some multiplex panels report a combined rhinovirus/enterovirus result. Colored discharge alone does not establish bacterial infection. Additional testing or imaging depends on severity, risk factors and suspected complications.

Pathophysiology


Key Mechanisms

  • Many rhinovirus types bind ICAM-1; minor-group types use LDL-receptor-family members, while rhinovirus C uses CDHR3. ICAM-1 is not the receptor for every rhinovirus.

  • The positive-sense RNA genome functions as mRNA. IRES-mediated translation produces a polyprotein that viral proteases cleave; viral RNA polymerase supports replication in the cytoplasm.

  • Host mediators, including kinins, increase vascular permeability and secretions. Symptoms are not simply the result of widespread epithelial destruction.

  • Rhinoviruses are classically acid labile, unlike many enteric picornaviruses. The nonenveloped capsid distinguishes them from enveloped influenza and coronaviruses.

  • Neural reflex stimulation causes sneezing and cough.

InvolvementDetails
Organs

Nose is the main organ involved, presenting with congestion, rhinorrhea, and sneezing due to viral infection.

Pharynx may be involved causing sore throat as part of upper respiratory tract symptoms.

Tissues

Nasal mucosa is the primary tissue affected, where viral replication and inflammation cause symptoms.

Respiratory epithelial infection alters local host responses and barrier function; extensive epithelial destruction is not required for an uncomplicated rhinovirus cold.

Cells

Epithelial cells of the nasal mucosa serve as the primary site of rhinovirus entry and replication.

Neutrophils infiltrate the nasal mucosa contributing to inflammation and symptom development.

Epithelial cells and innate immune pathways generate inflammatory mediators; mast-cell histamine release is not established as the main mechanism of ordinary rhinovirus colds.

Chemical Mediators

Histamine is central to allergic rhinitis, but nasal histamine does not consistently rise during experimental rhinovirus colds. This helps explain the limited benefit of antihistamines.

Interleukin-8 (IL-8) attracts neutrophils to the site of infection amplifying inflammation.

Bradykinin contributes to nasal mucosal swelling and pain sensation during infection.

Treatments


Pharmacological Treatments

  • Decongestants (e.g., pseudoephedrine, oxymetazoline)

    • Mechanism:
      • Stimulate alpha-adrenergic receptors causing vasoconstriction and reduced nasal mucosal edema

    • Side effects:
      • Topical nasal irritation

      • Rebound congestion with prolonged topical use

      • Systemic sympathomimetic effects, including increased blood pressure, palpitations or insomnia

    • Clinical role:
      • Optional short-term symptom relief in suitable patients. Use topical oxymetazoline for no more than 3 days to limit rebound congestion; oral products have systemic adverse effects.

  • Analgesics and antipyretics (e.g., acetaminophen, ibuprofen)

    • Mechanism:
      • Acetaminophen reduces pain and fever with little peripheral anti-inflammatory action. Ibuprofen inhibits cyclooxygenase and prostaglandin synthesis as an NSAID.

    • Side effects:
      • NSAIDs: GI irritation, ulceration or bleeding

      • Acetaminophen: liver injury with overdose or duplicate combination products

      • NSAIDs: renal injury, especially with dehydration or kidney disease

    • Clinical role:
      • Optional relief of troublesome pain or fever, with age-appropriate dosing and contraindication checks; these medicines do not eradicate rhinovirus.

  • Antihistamines (first-generation)

    • Mechanism:
      • H1-receptor blockade with additional anticholinergic and sedating effects; rhinovirus symptoms are not primarily an IgE-mediated histamine response.

    • Side effects:
      • Sedation

      • Dry mouth

      • Dizziness

    • Clinical role:
      • Limited short-term benefit in some adults, without sustained benefit or antiviral action; not routine cold treatment for children.

Non-pharmacological Treatments

  • Adequate hydration to maintain mucosal moisture and facilitate mucus clearance.

  • Rest as needed; honey may relieve cough in adults and children at least 1 year old, but must not be given to infants under 1 year.

  • Saline spray or drops may ease symptoms. For irrigation use distilled, sterile or previously boiled and cooled water, with appropriate saline preparation and device cleaning.

  • A clean cool-mist humidifier may improve comfort; avoid scalding steam and contaminated equipment.

Prevention


Pharmacological Prevention

  • No approved antiviral agents effectively prevent rhinovirus infection.

  • Intranasal interferons have been studied but are not routinely used due to side effects.

  • Oral zinc may modestly shorten some colds, but evidence and formulations vary and nausea or unpleasant taste can occur; it is not established routine prevention. Avoid intranasal zinc because of risk of prolonged or permanent anosmia.

  • No vaccine is currently available for the common cold caused by rhinovirus.

Non-pharmacological Prevention

  • Frequent handwashing reduces transmission by removing viral particles.

  • Reduce close exposure while ill and improve ventilation/cleaner air, particularly in crowded indoor settings.

  • Proper respiratory hygiene such as covering coughs and sneezes decreases spread.

  • Disinfecting commonly touched surfaces reduces fomite-mediated transmission.

  • Maintaining good overall health and adequate sleep supports immune defense.

Outcome & Complications


Complications

  • Secondary bacterial sinusitis can develop from impaired mucociliary clearance.

  • Acute otitis media is a common complication especially in children.

  • Exacerbation of asthma or chronic obstructive pulmonary disease may occur.

  • Lower respiratory tract infections such as bronchitis or pneumonia are rare but possible.

Short-term Sequelae Long-term Sequelae
  • Persistent cough lasting up to 3 weeks due to airway inflammation.

  • Postnasal drip causing throat irritation and hoarseness.

  • Transient fatigue and malaise during recovery phase.

  • Temporary anosmia or hyposmia due to nasal mucosal swelling.

  • No significant long-term sequelae typically result from uncomplicated common cold.

  • Rhinovirus is an important trigger of asthma exacerbations. Persistent or recurrent wheezing warrants assessment for underlying airway disease rather than assuming that every cold causes chronic hyperreactivity.

  • Persistent sinus symptoms require assessment for chronic rhinosinusitis or another condition rather than assuming persistent rhinovirus infection.

Differential Diagnoses


Common Cold (Rhinovirus) versus Influenza

Common Cold (Rhinovirus)

Influenza

Often gradual and nasal/throat-predominant, improving over about a week; cough may persist.

Often abrupt fever, myalgia and malaise, but mild or afebrile influenza can resemble a cold.

Rhinovirus NAAT may be positive when testing is indicated; negative influenza testing alone does not establish rhinovirus.

Influenza NAAT or antigen testing may detect infection; a negative rapid antigen result does not reliably exclude it.

Infection caused by rhinovirus

Infection caused by influenza A or B virus

Common Cold (Rhinovirus) versus Allergic Rhinitis

Common Cold (Rhinovirus)

Allergic Rhinitis

Acute onset of nasal congestion, sore throat, and cough often with mild systemic symptoms

Recurrent sneezing, nasal congestion, and clear rhinorrhea triggered by allergens without systemic symptoms

Viral infection is not an IgE-mediated disorder, but allergy can coexist; total IgE or eosinophil count cannot identify rhinovirus.

Allergen-linked symptoms and sensitization support allergy; normal total IgE or blood eosinophils do not exclude it.

First-generation antihistamines may provide small, short-term adult benefit without treating the virus.

Allergy commonly improves with antihistamines or intranasal corticosteroids, but response alone is not definitive.

Common Cold (Rhinovirus) versus Acute Bacterial Sinusitis

Common Cold (Rhinovirus)

Acute Bacterial Sinusitis

Usually improves during the first week, although cough or congestion may last longer.

Persistent symptoms beyond 10 days without improvement, severe onset or worsening after initial improvement raise concern.

Colored discharge and some facial pressure can occur during a viral cold.

High fever of at least 39 C with purulent discharge or facial pain for 3-4 days is a severe-onset bacterial pattern; discharge color alone is insufficient.

Antibiotics do not treat uncomplicated rhinovirus infection.

Selected bacterial sinusitis warrants antibiotics; treatment response alone is not a diagnostic test.

Common Cold (Rhinovirus) versus COVID-19

Common Cold (Rhinovirus)

COVID-19

Rhinovirus can circulate alongside SARS-CoV-2; lack of a known COVID exposure does not identify rhinovirus.

Exposure and local transmission influence probability, but no recognized contact is required.

A negative SARS-CoV-2 result does not prove rhinovirus; coinfection is possible.

SARS-CoV-2 NAAT or antigen testing is used when indicated. One negative antigen test may require repeat testing or NAAT.

Nasal congestion can reduce smell; systemic symptoms can occur.

Can closely resemble a cold. Smell/taste changes are variable, and their absence does not exclude COVID-19.

Common Cold (Rhinovirus) versus Respiratory Syncytial Virus (RSV) Infection

Common Cold (Rhinovirus)

Respiratory Syncytial Virus (RSV) Infection

Affects all ages and often causes mild disease, but can trigger asthma or severe illness in susceptible patients.

Affects all ages; bronchiolitis is characteristic in infants, while older or vulnerable adults can also develop severe disease.

Often upper-respiratory illness, but wheezing and lower-airway disease can occur.

Often cold-like; may progress to bronchiolitis or pneumonia with respiratory distress. Symptoms overlap.

Rhinovirus NAAT can detect infection; a negative RSV test does not establish rhinovirus and a positive test does not rule out coinfection.

RSV NAAT or antigen testing may identify infection; performance depends on the test and patient population.